Entering text into the input field will update the search result below

Adverse court ruling for Antares

  • A U.S. District Court denies Antares Pharma's (ATRS +1.1%) motion for a preliminary injunction against Medac Pharma to prevent it from selling its methotrexate auto-pen product if and when it earns regulatory approval. Antares sued Medac in February for patent infringement and filed a motion for preliminary injunction a month later. If the parties fail to settle, the litigation will proceed to a jury trial although no trial date has been set yet.

Recommended For You

About HALO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
HALO--
Halozyme Therapeutics, Inc.